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ABSTRACT
Recognition of pathogen-associated molecular patterns (PAMPs) of microorganisms by pathogen
recognition receptors induces signals responsible for the activation of genes important for an effective
host defence, especially those of pro-inﬂammatory cytokines. Toll-like receptors (TLRs) and lectin-like
receptors are the most important classes of pattern-recognition receptors. In addition to their effects on
the activation of host defence, recent studies suggest that pathogenic fungi can modulate or interfere
with the pattern recognition mechanisms of innate immunity, and can use pattern recognition receptors
as mechanisms of escape from host defence. Two major recognition receptor-mediated escape
mechanisms have been identiﬁed during infection with fungal pathogens: immunosuppression induced
by activation of certain pattern recognition receptors, especially induction of IL-10 release through TLR2;
and the blockade of TLR recognition by antigen modiﬁcation during the germination of yeasts into
hyphae. Thus, signals mediated by recognition receptors are not only beneﬁcial to the host, but in certain
situations can be used by pathogenic fungi to escape immune recognition and promote infection.
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INTRODUCTION
Within minutes of the invasion of the host by a
pathogenic microorganism, the innate immune
system is activated and coordinates the host
defence during the initial hours and days of the
infection. Although the innate immune system is
very effective in dealing with the vast majority of
invading pathogens, it has been believed for
many years to be non-speciﬁc and non-selective,
with speciﬁcity being conferred only by the
secondary activation of acquired immunity medi-
ated by T- and B-lymphocytes. This dogma of the
non-selective nature of the innate immune
response and, in particular, the presumed non-
speciﬁc recognition of microorganisms by phag-
ocytic cells, has been challenged by the recent
discovery of classes of receptors which are able to
recognise speciﬁc molecular patterns of patho-
genic microorganisms, called pattern-recognition
receptors (PRRs). The most important classes of
PRR are the Toll-like receptors (TLRs) and the
lectin-like receptors. TLRs recognise a wide vari-
ety of microbial structures, including lipopolysac-
charide (LPS) of Gram-negative bacteria (TLR4),
lipoteichoic acid and lipoproteins of Gram-posit-
ive bacteria (TLR2), bacterial DNA (TLR9), and
viral RNA (TLR3, TLR7 and TLR8) [1]. Lectin-like
receptors are PRRs specialised in the recognition
of polysaccharide chains of bacterial pathogens,
including the mannans and glucans of pathogenic
fungi [2]. Recognition of pathogens by PRRs leads
to release of pro-inﬂammatory cytokines and
activation of antibacterial mechanisms, and
modulates the initiation of acquired immunity
by the activation of dendritic cells.
PRRs MEDIATE PROTECTION
AGAINST FUNGAL PATHOGENS
Several classes of recognition receptors mediate
recognition of fungal pathogens. The structure of
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the fungal cell-wall, which is composed mainly of
carbohydrate chains such as mannans and glu-
cans, meant that the ﬁrst group of receptors
discovered to mediate fungal recognition were
the lectin receptors. Macrophage mannose recep-
tors recognise fungal mannans and mediate
recognition and phagocytosis of Candida spp. by
macrophages [3], while another lectin-like recep-
tor, DC-SIGN, participates in the phagocytosis of
Candida spp. and Aspergillus spp. by dendritic
cells [4]. In addition, the b–glucans of fungi are
recognised by several receptors, such as comple-
ment receptor-3 [5], and the speciﬁc receptor
dectin-1 [6]. However, the pathways by which
leukocytes activated many of their antifungal
mechanisms remained elusive until the discovery
of TLRs.
The ﬁrst suggestion of a role for TLRs in
antifungal host defence was provided by the
extreme susceptibility of Toll-deﬁcient Drosophila
to aspergillosis [7]. Shortly after the discovery of
the human homologues of Toll, it became appar-
ent that TLR2 ⁄TLR6 heterodimers recognise
zymosan, a structure derived from Saccharomyces
cerevisiae [8,9]. The cell-wall structure of Saccharo-
myces resembles closely that of the fungal patho-
gen Candida albicans, which prompted an
investigation of the role of TLRs in the host
defense against disseminated candidiasis. In the
ﬁrst description of the role of TLRs in a fungal
infection, it was demonstrated that the absence of
TLR4-mediated signals resulted in an increased
susceptibility to disseminated candidiasis in
TLR4-defective mice [10]. This effect was medi-
ated through decreased release of the chemokines
termed keratinocyte-derived chemokine (KC) and
macrophage inﬂammatory protein (MIP)-2, and
impaired recruitment of neutrophils at the site of
infection. It has also been reported that the
mannan components of the Candida cell-wall are
the structures recognised by TLR4, a process
which also requires CD14 [11].
Since these initial observations, further studies
have conﬁrmed the important role of TLRs in the
recognition of C. albicans and anti-candidal host
defence. The global role of TLRs in the host
defence against disseminated candidiasis was
demonstrated by the increased susceptibility of
MyD88- ⁄ - mice, an intracellular adaptor molecule
of the TIR domain, to C. albicans infection [12].
MyD88 was also involved in mediation of
cytokine synthesis by C. albicans, as well as
phagocytosis and killing of the yeast [12,13]. An
important mechanism for the recognition of
Candida and Saccharomyces spp. was demonstrated
by two independent studies showing collaborat-
ive recognition of fungal b-glucan by TLR2 and
the lectin-like receptor dectin-1 [14,15]. Experi-
mental models of disseminated candidiasis infec-
tion in TLR2- ⁄ - mice have also shown modulatory
effects of TLR2 on host defence [16–18]. In
contrast, TLR9 appeared to be less important for
host defence against C. albicans [18].
An important role of TLRs has also been
demonstrated in the recognition of Aspergillus
fumigatus. Invasive aspergillosis is a life-threaten-
ing infection which occurs predominantly in
immunocompromised patients. As the number
of immunocompromised patients has increased,
A. fumigatus has become the second most common
opportunistic fungal infection [19]. The involve-
ment of TLRs in the recognition of Aspergillus was
suggested for the ﬁrst time by Wang et al. [20],
who proposed TLR4, but not TLR2, as a receptor
for Aspergillus hyphae. Subsequent studies have
supported the hypothesis of TLR involvement in
the recognition of Aspergillus by showing the
important role of MyD88 in Asperillus-induced
cytokine production [18]. However, an exclusive
role for TLR4 in the recognition of Aspergillus
hyphae was not conﬁrmed. In contrast, both
TLR2 and TLR4 have been demonstrated to be
important for recognition of A. fumigatus [21–24]
and Aspergillus niger [23]. Similarly, TLR2 and
TLR4 are crucial for neutrophil stimulation in
aspergillosis [25]. The concept that TLR4-medi-
ated pro-inﬂammatory effects are protective
against invasive aspergillosis is supported
by data showing increased susceptibility of
TLR4- ⁄ - mice to A. fumigatus infection [18].
Signiﬁcantly less is known concerning the
interaction of the third major human fungal
pathogen, Cryptococcus neoformans, with TLRs.
Binding of C. neoformans glucuronoxylomannan
to TLR2 and TLR4 has been reported, followed by
NF-kB translocation in the case of interaction with
TLR4, but not TLR2 [26]. However, despite
induction of NF-kB activation, glucuronoxylo-
mannan interaction with TLR4 failed to result in
the release of pro-inﬂammatory cytokines [26].
More recently it has been shown that MyD88
and TLR2, but not TLR4, are required for
host defence against infection with C. neoformans
[27,28].
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PRO- AND ANTI- INFLAMMATORY
SIGNALS DURING INFECTION
Following activation of the innate immune sys-
tem, strong pro-inﬂammatory signals are gener-
ated, inducing inﬂammation and activation of the
host defence. After elimination of the invading
microorganisms, subsequent anti-inﬂammatory
signals are responsible for the resolution of
inﬂammation [29]. These signals are crucial, not
only for the return of the immune system to
homeostatic balance, but also for the protection of
the host against the deleterious effects of over-
whelming inﬂammation and for subsequent tis-
sue repair. Probably the best known example of
an out-of-control inﬂammatory reaction during
infection is the sepsis syndrome, in which gener-
alised inﬂammation, induced by overproduction
of cytokines, leads to hypotension, intravascular
coagulation and multiple organ failure, resulting
ultimately in death [30].
TLR-signals are involved in both the primary
induction of inﬂammation and the secondary
activation of anti-inﬂammatory mechanisms
(Fig. 1). TLRs are known to induce release of
anti-inﬂammatory cytokines, e.g., interleukin
(IL)-10, IL-4, IL-5 and IL-13 [31,32], and TLR2-
and TLR4-mediated signals have been shown to
mediate generation of down-modulating T-regu-
latory cells [16,33]. In line with this concept, the
absence of TLR2 or TLR4 results in increased
mortality following overwhelming inﬂammation
in certain experimental models, including those
of pneumococcal meningitis [34] or Bordetella
pertussis infection [35]. However, while TLR-
mediated anti-inﬂammatory signals are beneﬁcial
following the elimination of the pathogens, they
can induce dangerous immunosuppressive mech-
anisms if activated too early during a severe
infection, as described below.
FUNGAL PATHOGENS CAN USE
PRRs AS ESCAPE MECHANISMS
Recent studies of PRR biology have shown that,
while innate recognition is crucial for an efﬁcient
immune response, certain fungal pathogens use
PRR-based strategies to evade host defences. It
has been demonstrated that TLR2 ligation can
induce pro-inﬂammatory cytokines, but that this
effect is weaker than that mediated by TLR4 [36].
In contrast, TLR2 signals are strong mediators of
anti-inﬂammatory effects. The TLR2-induced
immunosuppression is either an exaggeration or
a premature activation of the normal anti-inﬂam-
matory effects of TLR stimulation, necessary
during the recovery phase of the infection for
reversing inﬂammation. The ﬁrst study investi-
gating the differential effects of TLR2 and TLR4
stimulation on dendritic cells reported the failure
of TLR2 ligands to induce release of IL-12 and
IFNc, producing conditions favourable for a
Th2-type response [31], and this was supported
by additional studies [32,37,38]. Investigations of
the molecular mechanism behind this phenom-
enon showed that engagement of TLR2 ⁄TLR1
heterodimers by the bacterial lipopeptide
Pam3Cys resulted in stabilisation of the transcrip-
tion factor c-Fos, a suppressor of IL-12, and that
this resulted in the Th2 bias [32].
These in-vitro data have been accompanied by
in-vivo studies demonstrating the immunosup-
pressive effects of TLR2 in fungal infections. A
study of anti-candidal properties of macrophages
has demonstrated that macrophages defective in
TLR2 exhibit increased ability to contain
C. albicans infection [39]. In line with this obser-
vation, it has been demonstrated that TLR2- ⁄ -
mice are more resistant to disseminated candidi-
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Fig. 1. Role of Toll-like receptor (TLR) signals in the
induction of inﬂammation and the activation of anti-
inﬂammatory mechanisms. TLRs induce release of both
pro-inﬂammatory cytokines, such as TNF and IFNc, and
anti-inﬂammatory cytokines, such as IL-10, IL-4, IL-5 and
IL-13. Whereas TLR4-mediated signals induce a more
prominent Th1-type response, TLR2-stimulation leads to a
more pronounced Th2-type anti-inﬂammatory cytokine
proﬁle.
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asis, and that this is accompanied by a Th1-bias in
these mice [16,18]. C. albicans induces immuno-
suppression through TLR2-mediated IL-10
release, and this leads to generation of
CD4+ CD25+ T-regulatory cells with immuno-
suppressive potential [16]. Similar data have been
reported for schistosomal lyso-phosphatidylser-
ine-induced TLR2 stimulation leading to genera-
tion of IL-10-producing T-regulatory cells [40].
The decreased survival after Candida infection in
TLR2- ⁄ - mice in another study was probably
caused by a different experimental design [17]. As
with Candida, tolerance induction by Borrelia
burgdorferi is conferred through TLR2-mediated
release of IL-10, and this has been proposed as
a mechanism by which to explain the immuno-
suppression of chronic Lyme borreliosis, with
persistence of the microorganisms in immuno-
competent hosts [41]. These effects of TLR2 are
reminiscent of those of other pathogen-recogni-
tion receptors, such as DC-SIGN or mannose
receptors, which also mediate microbial evasion
through their interaction with mannose-capped
lipoarabinomannan from mycobacteria and
induction of a Th2 bias [42,43].
In addition to the induction of anti-inﬂamma-
tory signals through TLRs, certain fungi have
developed strategies to either block or avoid their
recognition by TLRs and subsequent activation of
the innate defence. Thus, A. fumigatus evades
immune recognition by germination into hyphae,
with subsequent loss of TLR4-recognition, while
the TLR2-mediated IL-10 pathways remain intact,
thus shifting the balance towards a permissive
Th2-type proﬁle [22]. In recent experiments, it
was possible to document a similar evasion of
TLR4 recognition by Candida hyphae, which
stimulate mainly anti-inﬂammatory cytokines
through TLR2 [44], but which are unable to be
recognised by TLR4 and thereby stimulate IL-12
or IFNc synthesis [44,45].
TLR4 is not the only PRR targeted during
fungal germination. In a recent elegant study,
Gantner et al. [46] demonstrated that dectin-1
recognises the b–glucans at the level of budding
scars in the yeast, but that it cannot recognise the
b–glucans in the hyphae, where they are shielded
by a layer of mannans [46]. In this way, two major
recognition systems (TLR4 and dectin-1) are
unable to recognise candidal hyphae, shifting
the balance towards an anti-inﬂammatory re-
sponse (Fig. 2).
All these data suggest that fungal pathogens
use speciﬁc signals induced by PRRs to either
down-modulate the microbicidal functions of
leukocytes or to escape immune recognition.
CONCLUSIONS
The spectacular discoveries of the last few years
in the ﬁeld of PRRs have demonstrated convin-
cingly that innate immune activation by PRRs
is a crucial step in antifungal host defence
mechanisms. PRRs recognise PAMPs of fungi,
mediate production of cytokines, activate the
fungicidal mechanisms of leukocytes, and induce
maturation and activation of dendritic cells,
thereby providing a bridge between innate and
acquired immunity. However, it appears that
pathogenic fungi have evolved ways of exploit-
ing part of this recognition system to escape the
antifungal host defence mechanisms, either by
inducing TLR2-mediated immunosuppression or
simply by evading recognition by these classes
of receptors.
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Fig. 2. Evasion from pattern recognition during germina-
tion. Dimorphic fungi such as Candida albicans and Asperg-
illus fumigatus escape immune recognition during
germination from yeasts to hyphae. In contrast, yeasts
are recognised by three different recognition systems,
namely TLR4, dectin-1 and TLR2; the hyphae are recog-
nised only by TLR2.
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